endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

about the author

ENDPOINTS

editor@endpointsnews.com

author articles

Two months af­ter ink­ing a SPAC deal, Ren­o­va­cor taps new CMO; Cure­Vac reels in a new de­vel­op­ment chief from Mer­ck KGaA

4 years ago
Peer Review

New da­ta point to how Keytru­da changed lung can­cer treat­ment; A Hous­ton biotech earns ear­ly back­ers in quest to turn ...

5 years ago
News Briefing

Lega­cies: 60 bio­phar­ma pi­o­neers over 60 who helped birth a tech rev­o­lu­tion in the mak­ing

5 years ago
People
Special

The 20(+1) un­der 40: In­side the next gen­er­a­tion of biotech lead­ers

5 years ago
Special

Diem Nguyen tapped to lead 'point of in­flec­tion' at Xalud Ther­a­peu­tics; Di­ana Es­co­lar dances her way to Avro­bio CMO

5 years ago
Peer Review

Covid-19 roundup: Hack­ers start re­leas­ing 'ma­nip­u­lat­ed' Covid-19 vac­cine docs; Ex-FDA com­mish David Kessler to ...

5 years ago
Coronavirus

News brief­ing: Chi-Med en­trusts In­ma­gene with four pre­clin­i­cal pro­grams; Xofluza nets EU ap­proval for flu pre­ven­tion

5 years ago
News Briefing

News brief­ing: 10 years lat­er, teplizum­ab gets a sec­ond shot at an FDA OK; J&J files for ami­van­tam­ab ap­proval in ...

5 years ago
News Briefing

2020’s NDA list is packed with com­mer­cial firsts — from his­toric to hap­haz­ard. Have we reached a tip­ping point?

5 years ago
Special

News brief­ing: Mer­ck buys in­to A2's T cell ther­a­py plat­form; Small Soli­genix re­ports PhI­II fail in head and neck ...

5 years ago
News Briefing

Spe­cial re­port: Twen­ty ex­tra­or­di­nary women blaz­ing trails in bio­phar­ma R&D — Covid-19 and be­yond

5 years ago
People
Special

News brief­ing: In­tel­lia hits clin­ic with CRISPR ther­a­py; Vi­for con­tin­ues to spend, pay­ing up to $340M for DGF pro­gram

5 years ago
News Briefing

News brief­ing: Mer­ck preps FDA pitch af­ter adding more da­ta on V114; Bris­tol My­ers, Ex­elix­is get quick re­view for ...

5 years ago
News Briefing

News brief­ing: Pfiz­er on track to ear­ly '22 piv­otal read­out on he­mo­phil­ia A; Co­di­ak scales back IPO ex­pec­ta­tions

5 years ago
News Briefing

Covid-19 roundup: No­var­tis' Vas Narasimhan sees drugs as 'bridge' to vac­cines; Mod­er­na spot­lights el­der­ly re­spons­es ...

5 years ago
Coronavirus

Covid-19 roundup: Al­bert Bourla says Pfiz­er PhI­II is at 23,000 pa­tients, sub­mis­sion com­ing end of Oc­to­ber

5 years ago
R&D
Coronavirus

Covid-19 roundup: KHN: Fau­ci says Covid vac­cine tri­als could end ear­ly, if...; HHS plans $250M cam­paign to 'de­feat ...

5 years ago
Coronavirus

Covid-19 roundup: Just how much is the ‘first wave’ mar­ket for Covid-19 vac­cines worth? One top an­a­lyst sets the ...

5 years ago
Coronavirus

Covid-19 roundup: 34 AGs call for ‘march-in’ rights on remde­sivir; Hahn pleads with pub­lic to trust FDA's vac­cine ...

5 years ago
Coronavirus

Covid-19 roundup: J&J and BAR­DA agree to $1 bil­lion for 100 mil­lion dos­es; Plas­ma re­duces mor­tal­i­ty by 50% — ...

5 years ago
Coronavirus

Rare dis­ease start­up NFlec­tion scores $20M in Se­ries A haul; Gilead part­ner Gala­pa­gos signs pact with Ox­ford biotech

5 years ago
News Briefing

Take­da-part­nered Evox signs up to $1.2B pact with Lil­ly; New liq­uid biop­sy com­pa­ny launch­es with $12M Se­ries A

5 years ago
News Briefing

Mer­ck wins a third FDA nod for an­tibi­ot­ic; Mereo tack­les TIG­IT with $70M raise in hand

5 years ago
News Briefing

For­bion leads $62.5M round for neu­ro start­up as ex-Te­va R&D chief takes con­trol; CSL Behring inks gene ther­a­py pact ...

6 years ago
News Briefing
First page Previous page 11121314151617 Next page Last page
A service from the Financial Times